Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.730
-0.120 (-6.49%)
Feb 20, 2026, 2:34 PM EST - Market open
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $4.41 million as of February 20, 2026. Its market cap has decreased by -71.02% in one year.
Market Cap
4.41M
Enterprise Value
-1.25M
1-Year Change
-71.02%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $4.41M, a decrease of -92.30%. That is a compound annual growth rate of -42.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 4.71M | -19.42% |
| Dec 31, 2025 | 5.85M | -57.48% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
| Jun 25, 2021 | 57.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xenetic Biosciences | 5.22M |
| VivoSim Labs | 5.19M |
| Cyclerion Therapeutics | 5.18M |
| Processa Pharmaceuticals | 5.17M |
| Decoy Therapeutics | 5.10M |
| Bio Green Med Solution | 5.10M |
| MetaVia | 5.00M |
| Silexion Therapeutics | 4.94M |